By VNA / DA NANG Today
December 27, 2020, 10:07 [GMT+7]
Three first volunteers received the first shot of a dose of 50mcg of Nanocovax Covid-19 vaccine on December 26 morning.
One of the three first volunteers receiving first shots of 50mcg dose of Covid-19 vaccine (Photo: VNA)
Developed by the Nanogen Pharmaceutical Biotechnology JSC and the Vietnam Military Medical University, Nanocovax is Vietnam s first Covid-19 candidate vaccine to reach the human trial stage.
A total of 60 volunteers, aged 18-50, were selected for the first phase of the clinical trials. They are divided into three groups for receiving three doses of 25 mcg, 50 mcg and 75 mcg, respectively. The vaccination consists of two injections 28 days apart.